There is no information available yet.
The APAC MRDR has now enrolled 1,500 patients! Thank you and congratulations to all the hardworking Study Coordinators and Principal…
Congratulations to our sister registry, the Australian and New Zealand Myeloma and Related Diseases Registry (ANZ MRDR) who have now…
We are very excited to announce that two of our sites in China – Beijing Chaoyang Hospital and Renji Hospital,…
Tuesday 28 February is Rare Disease Day. Rare Disease Day is the globally-coordinated movement on rare diseases, working towards equity…
Please note that Monash University and the APAC MRDR will be closed from 22 December 2022 to 2 January 2023,…
In October the APAC MRDR welcomed three new sites from Malaysia. Ampang Hospital, Hospital Pulau Pinang (Penang General Hospital) and…
Missed the APAC MRDR Investigators’ Meeting for 2022? Watch the presentation below with talks from Professor Andrew Spencer, Dr Justin…
We are pleased to invite you to our APAC MRDR Investigators’ Meeting at the 19th International Myeloma Society (IMS) Annual…
Missed the APAC MRDR Investigators’ Meeting in 2021? Watch the first presentation below where Professor Andrew Spencer provides an overview…
The APAC MRDR has reached a significant milestone with 1000 study participants registered from Korea, Singapore, Malaysia and Taiwan. A…